Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

January 11, 2022

8 Views

Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

Q. Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

A. Dabrafenib

B. Dabrafenib plus vemurafenib

C. Dabrafenib plus trametinib

D. Dabrafenib plus ipilimumab

Answer: Dabrafenib plus trametinib

Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

Previous

Larotrectinib is a

Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

Next

In squamous cell lung cancer, which of the following drug is not effective

Related Articles

What is the most common type of bladder cancer?

What is the most common type of bladder cancer?

All of the below are symptoms of advanced bladder cancer except which one?

All of the below are symptoms of advanced bladder cancer except which one?

True or false? Bladder cancer affects mostly young women

True or false? Bladder cancer affects mostly young women

Which region in the u.s. Has the highest incidence rate of bladder cancer?

Which region in the u.s. Has the highest incidence rate of bladder cancer?

We will be happy to hear your thoughts

Leave a reply Cancel reply

You must be logged in to post a comment.